5 Compelling Reasons Why AbbVie's Dividend Will Keep on Growing
What's the best dividend stock in all of big pharma? I would argue that the hands-down winner is AbbVie (NYSE: ABBV). The big biotech has the total package for dividend-seeking investors: a high yield, manageable payout ratio, and a long record of dividend increases.
I listened to several members of AbbVie's executive team, including CEO Rick Gonzalez, talk about their company's future at the Morgan Stanley healthcare conference on Tuesday. It was an interesting discussion. One of the biggest takeaways I had as someone who regularly covers AbbVie is this: The dividend will keep on growing. Here are five reasons why.
Image source: Getty Images.
Source: Fool.com
Amgen Inc. Stock
€308.25
0.100%
The stock is an absolute favorite of our community with 25 Buy predictions and no Sell predictions.
On the other hand, the target price of 304 € is below the current price of 308.25 € for Amgen Inc., so the potential is actually -1.38%.
